データなし
データなし
瑞银:哈里斯取胜将利好公用事业债,特朗普则提振能源
Dr. Reddy's Laboratories Agreed To Partially Defer A Milestone Payment From Citius Oncology, Inc., Due On September 9, 2024, Upon FDA Approval Of LYMPHIR, Without Penalty, Pending Further Discussions, As Per Their 2021 Asset Purchase Agreement
Asian Equities Traded in the US as American Depositary Receipts Trend Higher in Thursday Trading
Dr. Reddy's Issues Clarification Regarding Allegations Tied To Engagement With Agora Advisory; Confirms Engagement Of Dhaval Buch From October 2020 To April 2021, Prior To Madhabi Buch's SEBI Chairpersonship; Asserts Compliance With Laws And Denies...
Dr. Reddy's Receives FDA Form 483 With Three Observations Following Inspection At Srikakulam Facility
Asian Equities Traded in the US as American Depositary Receipts Rise in Wednesday Trading
データなし
データなし